Masayuki Kurosaki

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama et al. · Nature Genetics · 2009 · 2.1K citations

Life Sciences, Immunology, Pharmacology +16

Mutations in the Nonstructural Protein 5a Gene and Response to Interferon in Patients with Chronic Hepatitis C Virus 1b Infection

Nobuyuki Enomoto, Ikuo Sakuma, Yasuhiro Asahina et al. · New England Journal of Medicine · 1996 · 1K citations

Life Sciences, Molecular Biology, Molecular Genetics +14

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

Naoya Enomoto, Ikuo Sakuma, Yasuhiro Asahina et al. · Journal of Clinical Investigation · 1995 · 634 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12